SCNI Stock Analysis: Buy, Sell, or Hold?
SCNI - Scinai Immunotherapeutics Ltd. American Depositary Shares
$0.71
-0.03 (-4.05%)
▼
5d:
-3.66%
30d:
+11.09%
90d:
-27.55%
HOLD
MODERATE Confidence
Analysis Updated: May 1, 2026 12:00 AM ET
Earnings: May 06, 2026
2d
Get Alerted When SCNI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: SCNI is 7.6% above its trading range ($0.66). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: SCNI is 7.6% above its trading range ($0.66). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: SCNI is currently trading at $0.71, which is considered fair relative to its 30-day fair value range of $0.55 to $0.66.
Technical Outlook: Technically, SCNI is in a downtrend. Immediate support is located at $0.45, while resistance sits at $1.05. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: SCNI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $700.00 (+98491.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SCNI is in a downtrend. Immediate support is located at $0.45, while resistance sits at $1.05. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: SCNI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $700.00 (+98491.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.55 -
$0.66
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
76.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-4.1%)
- BULLISH: Trading 98491.5% below Wall St target ($700.00)
- CAUTION: Extended 7.6% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$0.55 -
$0.66
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.45
Resistance Level
$1.05
Current Trend
Downtrend
Technical data as of
May 1, 2026
Fundamental Context
Wall Street Target
$700.00
(+98491.5%)
Revenue Growth (YoY)
30.6%
Earnings Growth (YoY)
87.2%
Share & Embed Analysis
Last updated: May 03, 2026 12:18 AM ET
Data refreshes hourly during market hours. Next update: 1:18 AM
Data refreshes hourly during market hours. Next update: 1:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNI showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 62 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 56 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 54 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$298 | 55 HOLD |